COMPUGROUP MED COCOMPUGROUP MED COCOMPUGROUP MED CO

COMPUGROUP MED CO

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.08 B‬CHF
0.459CHF
‪42.67 M‬CHF
‪1.10 B‬CHF
‪22.69 M‬
Beta (1Y)
0.42
Employees (FY)
‪9.2 K‬
Change (1Y)
−30 −0.33%
Revenue / Employee (1Y)
‪119.98 K‬CHF
Net income / Employee (1Y)
‪4.64 K‬CHF

About COMPUGROUP MEDICAL SE & CO. KGAA


CEO
Daniel Gotthardt
Website
Headquarters
Koblenz
Founded
1987
ISIN
DE000A288904
FIGI
BBG007FJN064
CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. It operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer and Health Management Information Systems (CHS). The AIS segment focuses on practice management software and electronic medical records for office-based physicians, dentists, medical care centers and physician's networks. The PCS segment deals with the integrated clinical, administrative and financial software applications for retail pharmacies. The HIS segment handles clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The HCS segment involves customers within the healthcare sector that are outside the healthcare providers. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of COP is 19.927 CHF — it has decreased by −1.01% in the past 24 hours. Watch COMPUGROUP MED CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange COMPUGROUP MED CO stocks are traded under the ticker COP.
We've gathered analysts' opinions on COMPUGROUP MED CO future price: according to them, COP price has a max estimate of 26.90 CHF and a min estimate of 9.28 CHF. Watch COP chart and read a more detailed COMPUGROUP MED CO stock forecast: see what analysts think of COMPUGROUP MED CO and suggest that you do with its stocks.
COP reached its all-time high on Oct 15, 2021 with the price of 75.981 CHF, and its all-time low was 14.499 CHF and was reached on Nov 27, 2024. View more price dynamics on COP chart.
See other stocks reaching their highest and lowest prices.
COP stock is 1.34% volatile and has beta coefficient of 0.42. Track COMPUGROUP MED CO stock price on the chart and check out the list of the most volatile stocks — is COMPUGROUP MED CO there?
Today COMPUGROUP MED CO has the market capitalization of ‪1.06 B‬, it has increased by 27.64% over the last week.
Yes, you can track COMPUGROUP MED CO financials in yearly and quarterly reports right on TradingView.
COMPUGROUP MED CO is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
COP earnings for the last quarter are 0.33 CHF per share, whereas the estimation was 0.28 CHF resulting in a 16.67% surprise. The estimated earnings for the next quarter are 0.33 CHF per share. See more details about COMPUGROUP MED CO earnings.
COMPUGROUP MED CO revenue for the last quarter amounts to ‪201.42 M‬ CHF, despite the estimated figure of ‪265.79 M‬ CHF. In the next quarter, revenue is expected to reach ‪282.06 M‬ CHF.
COP net income for the last quarter is ‪8.13 M‬ CHF, while the quarter before that showed ‪13.41 M‬ CHF of net income which accounts for −39.36% change. Track more COMPUGROUP MED CO financial stats to get the full picture.
Yes, COP dividends are paid annually. The last dividend per share was 0.99 CHF. As of today, Dividend Yield (TTM)% is 4.57%. Tracking COMPUGROUP MED CO dividends might help you take more informed decisions.
COMPUGROUP MED CO dividend yield was 2.64% in 2023, and payout ratio reached 113.77%. The year before the numbers were 1.39% and 35.58% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 3, 2025, the company has ‪9.20 K‬ employees. See our rating of the largest employees — is COMPUGROUP MED CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COMPUGROUP MED CO EBITDA is ‪225.57 M‬ CHF, and current EBITDA margin is 22.81%. See more stats in COMPUGROUP MED CO financial statements.
Like other stocks, COP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COMPUGROUP MED CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COMPUGROUP MED CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COMPUGROUP MED CO stock shows the strong sell signal. See more of COMPUGROUP MED CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.